These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33550696)

  • 1. Long-term joint outcomes of regular low-dose prophylaxis in Chinese children with severe haemophilia A.
    Wu Y; Lu J; Zhou Y; Li K; Liu Y; Liu S; Li Z; Zhao Y; Poon MC; Xiao J
    Haemophilia; 2021 Mar; 27(2):237-244. PubMed ID: 33550696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term health-related quality of life and related factors in children with severe hemophilia A who received regular low-dose prophylaxiss].
    Li Z; Zhou Y; Zhang SN; Li KX; Zhao YQ; Wang SJ; Xiao J
    Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(29):2745-2750. PubMed ID: 39075994
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the efficacy and safety of 12-month low-dose factor VIII tertiary prophylaxis vs on-demand treatment in severe haemophilia A children.
    Chozie NA; Primacakti F; Gatot D; Setiabudhy RD; Tulaar ABM; Prasetyo M
    Haemophilia; 2019 Jul; 25(4):633-639. PubMed ID: 31044491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-inhibitors of metalloproteinase-1 and vascular-endothelial growth-factor in severe haemophilia A children on low dose prophylactic recombinant factor VIII: Relation to subclinical arthropathy.
    Andrawes NG; Saker HM; Salah El-Din NY; Abd Elhakim Hussain M
    Haemophilia; 2020 Jul; 26(4):607-614. PubMed ID: 32445517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe haemophilia A children on low-dose tertiary prophylaxis showed less joint deterioration and better maintenance of functional independence than children on on-demand treatment: A 6-year follow-up study.
    Liu Y; Chen L; Li K; Shi M; Poon MC
    Haemophilia; 2020 Sep; 26(5):779-785. PubMed ID: 32700412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of joint damage in hemophilic children with early prophylaxis].
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of short-term full-dose prophylaxis in adult Chinese patients with severe hemophilia A].
    Sun X; Zhuang J; Zhou X; Li H; Liu Z; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1222-1227. PubMed ID: 30377129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose factor VIII prophylaxis therapy on bone mineral density and 25(OH) vitamin D level in children with severe haemophilia A.
    Gamal Andrawes N; Hashem Fayek M; Salah El-Din N; Atef Mostafa R
    Haemophilia; 2020 Mar; 26(2):325-332. PubMed ID: 31884718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand.
    Oldenburg J; Zimmermann R; Katsarou O; Theodossiades G; Zanon E; Niemann B; Kellermann E; Lundin B;
    Haemophilia; 2015 Mar; 21(2):171-179. PubMed ID: 25470205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic treatment with low- and intermediate-dose factor VIII in children with severe hemophilia A: comprehensive evaluation of joint outcomes and correlation analysis].
    Zhuang JM; Sun XY; Zhou X; Liu ZQ; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):496-501. PubMed ID: 29735454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of FVIII doses on joint structure and function in adolescents with severe hemophilia A: mid-term results of a prospective cohort study].
    Meng L; Zhuang J; Sun X; Liu Z; Zhou X; Liu H; Zhou F; Li Y; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):536-542. PubMed ID: 33963712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of prophylaxis with recombinant factor VIII in Chinese pediatric patients with hemophilia A: a multi-center, retrospective, non-interventional, phase IV (ReCARE) study.
    Li C; Zhang X; Zhao Y; Wu R; Hu Q; Xu W; Sun J; Yang R; Li X; Zhou R; Lian S; Gu J; Wu J; Hou Q
    Curr Med Res Opin; 2017 Jul; 33(7):1223-1230. PubMed ID: 28326849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose prophylaxis in Tunisian children with haemophilia.
    Gouider E; Jouini L; Achour M; Elmahmoudi H; Zahra K; Saied W; Meddeb B
    Haemophilia; 2017 Jan; 23(1):77-81. PubMed ID: 27943510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.
    Feldman BM; Rivard GE; Babyn P; Wu JKM; Steele M; Poon MC; Card RT; Israels SJ; Laferriere N; Gill K; Chan AK; Carcao M; Klaassen RJ; Cloutier S; Price VE; Dover S; Blanchette VS
    Lancet Haematol; 2018 Jun; 5(6):e252-e260. PubMed ID: 29731369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of health-related quality of life of boys with severe haemophilia A in China: comparing on-demand to prophylaxis treatment.
    Wu R; Sun J; Xiao J; Liu Y; Xue F; Wang H; Tang L; Zhao Y; Li K; Yang R; Hu Y; Luke KH; Poon MC; Blanchette VS; Usuba K; Young NL
    Haemophilia; 2017 May; 23(3):430-436. PubMed ID: 28345299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients.
    Arvanitakis A; Jepsen C; Andersson NG; Baghaei F; Astermark J
    Haemophilia; 2024 May; 30(3):671-677. PubMed ID: 38575549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
    Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HEAD-US-C quantitative ultrasound assessment scale in evaluation of joint damage in patients with moderate or severe hemophilia A received on-demand versus prophylaxis replacement therapy].
    Li J; Liu W; Guo XJ; Ding XL; Lyu BM; Xiao J; Sun QL; Li DS; Zhang WF; Zhong JC; Li CP; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Oct; 39(10):817-821. PubMed ID: 30369202
    [No Abstract]   [Full Text] [Related]  

  • 19. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China.
    Wu R; Luke KH; Poon MC; Wu X; Zhang N; Zhao L; Su Y; Zhang J
    Haemophilia; 2011 Jan; 17(1):70-4. PubMed ID: 20579111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using routine Haemophilia Joint Health Score for international comparisons of haemophilia outcome: standardization is needed.
    Nijdam A; Bladen M; Hubert N; Pettersson M; Bartels B; van der Net J; Liesner R; Petrini P; Kurnik K; Fischer K
    Haemophilia; 2016 Jan; 22(1):142-7. PubMed ID: 26179669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.